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Retinal vein occlusion (RVO) is the second most common retinal vascular diseases and there are only a few Asian population-based
studies with small samples. Hypertension is one of a modiﬁable risk factor of RVO, but no recent studies have shown the relationship
between RVO and hypertension control status. We aimed to investigate the prevalence of RVO and its associated factors in an adult
Korean population.
A nationwide population-based, cross-sectional study. We enrolled 37,982 participants from the Korea National Health and
Nutrition Examination Survey who were 19 years or older and who had undergone ophthalmologic exams from 2008 through 2012.
All participants underwent a comprehensive ophthalmic examination, standardized ophthalmic and health interviews, and laboratory
investigations. Digital fundus photographs were interpreted by retinal specialists who investigated for the presence of RVO. The
prevalence of RVO was then estimated. RVO-associated factors were determined using step-wise logistic regression analyses. We
also performed a subgroup analysis to evaluate the association between hypertension and RVO according to hypertension control
status and antihypertensive medication use.
Of those enrolled participants, 25,765 participants met our study criteria and were included in the analyses. The overall RVO
prevalence (n=205) was 0.6±0.1% (0.6±0.1% for branch RVO and<0.1% for central RVO), and no sex differences were observed.
In multivariate logistic regression analyses after adjusting for all potential risk factors, we found the following factors to be signiﬁcantly
associated with RVO: old age (odds ratio (OR)=1.72, 95% CI: 1.27–2.34), hypertension (OR=2.56, 95% CI: 1.31–5.08), history of
stroke (OR=2.08, 95% CI: 1.01–4.45), and hypercholesterolemia (OR=1.84, 95% CI: 1.01–3.35). In a subset of participants with
hypertension, participants with uncontrolled hypertension (OR=3.46, 95% CI: 1.72–6.94) and unmedicated hypertension (OR=
4.12, 95% CI: 2.01–8.46) were more signiﬁcantly associated with RVO than participants without hypertension.
RVO prevalence in Korea was moderate relative to that in the rest of the world, and RVO-associated factors were similar to those
identiﬁed in other population-based studies. Well-controlled hypertension and antihypertensive medication showed inverse
association with RVO.
Abbreviations: BDES = Beaver Dam Eye Study, BMES = Blue Mountains Eye Study, BMI = body mass index, BRVO = branch
retinal vein occlusion, CIEMS = Central India Eye and Medical Study, CKD = chronic kidney disease, CRVO = central retinal vein
occlusion, eGFR= estimated glomerular ﬁltration rate, KNHANES=Korea National Health and Nutrition Examination Survey, RNFL=
retinal nerve ﬁber layer, RVO = retinal vein occlusion, SEEDS = Singapore Epidemiology of Eye Disease Study, SiMES = Singapore
Malay Eye Study, VCDR = a vertical cup-to-disc ratio.
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Retinal vein occlusion (RVO) is the second most common retinal
vascular diseases following diabetic retinopathy. RVO causes
macular edema or vitreous hemorrhage and can lead to visual
disturbance.[1–3] RVO pathogenesis is generally due to compres-
sion of the venous lumen by arterial hemodynamic alterations
and/or inﬂammation.[4] RVO prevalence ranges from 0.3% to
1.6% according to several reports, including cohort studies, and
some have suggested that RVO is associated with either systemic
disorders (such as hypertension or diabetes) or ophthalmic
disorders (such as ocular hypertension or glaucoma).[1,5–13]
These data were mostly obtained from epidemiologic studies in
Western populations, while data from Asian samples remain
insufﬁcient for robust analyses; most Asia-based studies included
fewer than 100 subjects.[7,8,10,12,13]
Hypertension is one of the major cardiovascular risk factors
and is usually managed with antihypertensive drugs and/or
lifestyle modiﬁcation.[14] Most epidemiological studies agree that
hypertension is an important RVO risk factor. However, little is
known about whether hypertension control and antihypertensive
medication reduce RVO risk.[1]
The purpose of this study was to use a nationwide health
survey to investigate the prevalence of RVO according to age and
sex and to identify possible risk factors of RVO, especially when
hypertension is being controlled with or without antihypertensive
medication.
2. Methods
2.1. Study design and population
Data from the Korea National Health and Nutrition Examina-
tion Survey (KNHANES) were reviewed for this study. The
KNHANES is an ongoing cross-sectional, nationwide, popula-
tion-based survey of the health and nutritional status of
noninstitutionalized South Korean people, beginning in 1998.
It is based on a complex, stratiﬁed, multistage, clustered
probability design in order to obtain a representative sample
of the Korean population. Details of the KNHANES sample
recruitment strategy have been described elsewhere.[15–17] The
KNHANES consists of 3 parts: the Health Interview Survey, the
Health Examination Survey, and the Nutritional Survey. The
ophthalmologic interviews and exams were only conducted from
July 2008 to December 2012. Of the 45,810 participants enrolled
over the 5-year period in which ophthalmologic data were
collected, 37,982 participants participated in the ophthalmologic
survey. Fundus photography was performed only in adults aged
19 years or older; therefore, we included participants ≥19 years
old who underwent ophthalmologic interviews and exams as well
as general health interviews and exams. Participants were
excluded from our analyses if they did not have gradable fundus
photographs due to poor image quality or were missing
examination or interview data. However, participants who
had unilateral RVO but their unreadable fundus photograph
corresponded to the unaffected eye were included in the study. All
participants provided written informed consent, and this study
design was reviewed and approved by the Institutional Review
Board (IRB) of the Korean Centers for Diseases Control and
Prevention and by the IRB of Hanyang University Guri Hospital.
2.2. Data collection
We selected possible risk factors from the KNHANES open-
access data based on previous RVO epidemiologic studies. The2health interview survey consisted of standardized questionnaires
including demographic and socioeconomic information and
current or previous medical conditions. Monthly household
income (quartiles of household income) and education level
(elementary school or less, middle or high school, college or
more) were collected as socioeconomic factors. Patients were
categorized into 1 of 2 smoking statuses: either current smoker (a
lifetime history of smoking more than 5 packs of cigarettes or
smoking at the time of the interview) or nonsmoker (all categories
of smoking other than current smoker). Patients were categorized
into 1 of 2 alcohol-drinking statuses: regular alcohol drinker
(currently drinking alcohol more than once per month) or
nondrinker (all categories of alcohol drinking other than regular
alcohol drinker). Individual medical histories were obtained by
self-reported questionnaires, including data on history of angina,
myocardial infarction, and stroke. However, other individual
medical histories, such as hypertension or diabetes, were not used
in this study.
The health examination survey included anthropometric data,
blood pressure, and biochemical data. Waist circumference,
height, and weight of participants were measured by speciﬁcally
trained examiners. Body mass index (BMI) was calculated by
dividing weight in kilograms by height in meters squared (kg/m2).
Blood pressure was measured 3 times on the right arm after at
least 5minutes of rest in a seated position (Baumanometer; W.A.
BaumCo., Copiague, NY).We calculated the ﬁnal blood pressure
value by averaging the second and third blood pressure
measurements. For the routine blood test, blood samples were
collected after at least an 8-hour fasting period andwere analyzed
within 24hours after transport to a certiﬁed laboratory. From the
blood sera data, fasting glucose, glycated hemoglobin (HbA1c),
total cholesterol, triglycerides, high-density lipoprotein, low-
density lipoprotein, white blood cell count, hematocrit, ferritin,
vitamin D, blood urea nitrogen, and creatinine were all analyzed
for this study.
Ophthalmology-focused interviews were performed using self-
reported questionnaires, including past or current medical or
surgical conditions relevant to ophthalmology, including history
of cataract surgery. Exams were performed by an ophthalmolo-
gist who had been periodically trained and certiﬁed by the Korean
Ophthalmological Society (KOS) National Epidemiologic
Survey Committee. Intraocular pressure (Goldmann applanation
tonometry) and refractive errors (automatic refractometry,
KR-8800; Topcon, Tokyo, Japan) were measured. Slit-lamp
biomicroscopy was performed to identify any anterior segment
abnormalities and to measure the chamber depth. Nonmydriatic
45° digital fundus photography (TRC-NW6S; Topcon) was
performed on patients who participated in the ophthalmologic
exams and were 19 years or older. If participants had a history of
diabetes, random glucose level higher than 200mg/dL, or
suspicious diabetic retinopathy ﬁndings on nonmydriatic fundus
photography, 7 standard ﬁeld photographs were obtained after
pharmacological pupil dilation. Automated visual ﬁeld testing
using the screening program N-30-1 (Humphrey Matrix
frequency-doubling perimeter; Carl Zeiss Meditec, Inc., Dublin,
CA) was performed on participants who had elevated intraocular
pressure (≥22mm Hg), a horizontal or vertical cup to disc ratio
≥0.5, violation of the ISNT rule (neuroretinal rim broadest in the
inferior (I) area in the normal eye, followed by the superior (S),
nasal (N), and temporal (T) areas), an optic disc hemorrhage, or a
retinal nerve ﬁber layer (RNFL) defect. Each fundus image was
preevaluated onsite by ophthalmologists at the time of the
examination (normal vs abnormal) and all images were sent to a
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retinal specialists who participated in the Epidemiologic Survey
Committee of the KOS. Final grading was determined by 1 retinal
specialist (J.P.S.) after resolving interpreting discrepancies. RVO
was categorized as branch RVO (BRVO) and central RVO
(CRVO) and deﬁned according to a standardized protocol
proposed in previous studies.[1,5,6] Recent CRVO was character-
ized by retinal edema, optic disc hyperemia or edema, scattered
superﬁcial and deep retinal hemorrhages, and venous dilation.
Old CRVOs were characterized by occluded and sheathed retinal
veins or vascular anastomosis at the optic disc. BRVOs involved a
localized area of the retina in the sector of the obstructed venules
and were characterized by scattered superﬁcial and deep retinal
hemorrhages, venous dilation, intraretinal microvascular abnor-
malities, and occluded and sheathed retinal venules. A patient
was determined to have RVO if either of the eyes had BRVO or
CRVO. For analyzing eye-speciﬁc factors such as glaucoma,
refractive errors, history of cataract operation, and ocular
perfusion pressure, we obtained ocular information from 1 eye
with RVO. Even in cases with bilateral RVOs, ocular data from
only 1 eye (right eye) was selected for analysis.2.3. Variable deﬁnitions
Several new variables were deﬁned for this study from the
KNHANES raw data. Hypertension presence was deﬁned as
systolic pressure>140mmHg,diastolic pressure>90mmHg,or a
current prescription for antihypertensive medication. Diabetes
presence was deﬁned as fasting glucose >126mg/dL or a current
prescription for antiglycemic medication. Hypercholesterolemia
was deﬁned as a total cholesterol concentration >240mg/dL or a
current prescription for anticholesterol medication. Pulse pressure
was deﬁned as the difference between the systolic and diastolic
pressure measurements. Metabolic syndrome was deﬁned using
previously known criteria proposed by the International Diabetes
Federation in 2009.[18] We identiﬁed cases of chronic kidney
disease (CKD) by calculating the eGFR (estimated glomerular
ﬁltration rate) using the Modiﬁcation of Diet in Renal Diseases
Study formula: eGFR=186.3 (serum creatinine)1.154
age0.2030.742 (for women).[19] CKD was deﬁned as eGFR
value <60mL/min/1.73m2.[20] Glaucoma was deﬁned using the
International Society of Geographical and Epidemiological
Ophthalmology classiﬁcation criteria. Category 1 requires both
a visual ﬁeld defect consistent with glaucoma as well as a vertical
cup-to-disc ratio (VCDR) ≥0.7, asymmetry of the VCDR ≥0.2, or
presence of an RNFL defect; category 2 (when the visual ﬁeld test
was inconclusive) required VCDR ≥0.9, asymmetry of the VCDR
≥0.3, or presence of an RNFL defect with violation of the ISNT
rule; category 3 (when no visual ﬁeld testing or optic disc
examination was available) required a visual acuity <20/400 and
an intraocular pressure greater than 21mm Hg.[21] ocular
perfusion pressure was determined as two-thirds of the mean
arterial bloodpressure (two-thirds of the diastolic plus one-third of
the systolic value) minus the intraocular pressure.2.4. Subgroup analysis
To analyze the association between hypertension and RVO in
detail, participants with hypertension were divided according to
hypertension control status and antihypertensive medication
use.[14] Stage 1 hypertension was deﬁned as systolic pressure
>140mm Hg or diastolic pressure >90mm Hg. Stage 2
hypertension was deﬁned as systolic pressure >160mm Hg or3diastolic pressure >100mm Hg. Controlled hypertension was
deﬁned as systolic pressure 140mm Hg and diastolic pressure
90mm Hg among patients taking antihypertensive medication.
Uncontrolled hypertension was deﬁned as systolic pressure>140
mm Hg or diastolic pressure >90mm Hg among patients taking
antihypertensive medication. We analyzed the association
between RVO and hypertension control status regardless of
antihypertensive medication use. We also compared the associa-
tion of RVO between participants with and without antihyper-
tensive medication use.
2.5. Statistical analysis
Statistical analyses for a complex sampling design were
performed using SPSS for Windows software, version 18.0
(SPSS, Inc., Chicago, IL). According to the statistical guideline
from the Korea Centers for Disease Control and Prevention, we
organized a new dataset integrating the 5-year data and applied
adjusted weights. Baseline characteristics of enrolled participants
are presented as mean± standard error (SE) for continuous
variables and as percentage (%)±SE for categorical variables and
were compared using the independent T test and the Chi-square
test, respectively. Based on the difference between baseline
characteristics of RVO and non-RVO participants, we selected
potential risk factors with a P-value <0.1 for logistic regression
analyses. A step-wise approach was used to determine which
factors had signiﬁcant associations with RVO. In ﬁrst step, simple
linear regression analyses were performed to identify associations
between risk factors and RVO. Factors associated with an
increased RVO risk with a P-value <0.1 were entered into
multivariate logistic regression analyses. In next step, we
calculated odds ratios (OR) and 95% conﬁdence intervals (CI)
after adjusting for age and all other confounders. Factors that
yielded a P-value 0.05 were considered statistically signiﬁcant.
3. Results
Of all the participants who underwent an ophthalmic survey
(N=37,982), 25,765 were eligible for this study (205 partic-
ipants with RVO and 25,560 participants without RVO). We
excluded 12,223 participants because they were younger than 19
years; had a poor-quality, ungradable fundus image on either eye;
or were missing survey data. Participants with RVO in 1 eye but
whose unreadable fundus was for the fellow eye were included
(6 participants) (Fig. 1).
3.1. Prevalence of RVO
The overall prevalence of any type of RVOwas 0.6±0.1% in the
Korean population older than 19 years. There was no signiﬁcant
difference in RVO prevalence between males and females (0.6±
0.1% in both sexes). When we limited our analyses to
participants older than 40 years, the prevalence increased to
1.0±0.1%. BRVO prevalence was 0.6±0.1% (80 male
participants, 117 female participants), whereas CRVO preva-
lence was much lower at 0.1% (3 male participants and 6 female
participants); again there was no prevalence difference for either
subtype by sex. RVOwas rarely observed in participants younger
than 40 years, and no CRVO was found in participants younger
than 60 years (Table 1).
3.2. Risk factors associated with RVO
Regarding sociodemographic factors, participants with RVO
were more likely to be older (62.7±1.2 vs 44.3±0.2 years, P<
Figure 1. Flow chart for selection of study participants.
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0.5% in proportion of lower quartile, P<0.001), and have a
lower education level (53.1±4.3 vs 30.4±0.6% in proportion of
high school or less, P<0.001) than participants without RVO.
General medical conditions, such as the presence of diabetes
(14.6±3.5 vs 7.7±0.2%, P=0.011), hypertension (70.2±3.8 vs
25.6±0.4%, P<0.001), CKD (5.8±1.7 vs 1.5±0.1%, P=
0.010), and previous stroke (7.5±1.8 vs 1.2±0.1%, P<0.001),
were more frequent among participants with RVO than those
without. Regarding the biochemical factors, fasting glucose
(103.1±1.9 vs 96.4±0.2mg/dL, P=0.026) and total cholesterol
(199.9±4.2 vs 187.0±0.3mg/dL, P=0.004) were signiﬁcantly
higher in participants with RVO than in those without RVO.
Glaucoma (14.6±3.2 vs 5.3±0.2%, P<0.001), higher ocular
perfusion pressure (49.0±3.8 vs 37.4±1.1mm Hg, P=0.005),
history of cataract surgery (2.1±0.9 vs 0.8±0.1%, P=0.018),
and hyperopic refractive errors (0.9±0.2 vs 0.4±0.0 diopters,
P<0.001) were more frequently observed in participants with
RVO than in those without RVO. Detailed baseline character-
istics are shown in Table 2.Table 1
Prevalence of retinal vein occlusion according to age, sex, and retin
Age, y BRVO CRVO
19–29 <0.1 (1) 0 (0)
30–39 <0.1 (3) 0 (0)
40–49 0.3±0.1 (13) 0 (0)
50–59 0.8±0.2 (35) 0 (0)
60–69 1.4±0.2 (63) <0.1 (1)
70–79 2.5±0.3 (71) 0.3±0.1 (5)
80+ 2.1±0.7 (11) 0.3±0.2 (3)
Total 0.6±0.1 (197) <0.1 (9)
Crude prevalence was expressed as weighted estimate (%) (95% conﬁdence interval, standard error [%
BRVO=branch retinal vein occlusion, CRVO= central retinal vein occlusion.
4Table 3 shows the RVO-associated factors as determined by
logistic regression analysis. According to univariate logistic
regression analysis, the following factors were signiﬁcantly
associated with RVO (P<0.01): age, household income,
education level, HbA1c, diabetes, pulse pressure, BMI, fasting
glucose, hypertension, hypercholesterolemia, history of stroke,
CKD, glaucoma, history of cataract operation, and refractive
errors. Metabolic syndrome was statistically signiﬁcant as a risk
factor in univariate analysis (OR=2.14, 95% CI: 1.49–3.07) but
was not signiﬁcant in age-adjustedmultivariate logistic regression
analysis (age-adjusted OR [aOR]=1.08, 95% CI: 0.74–1.56).
We excluded metabolic syndrome from the multivariate logistic
regression analysis because the deﬁnition of metabolic syndrome
included various components that overlapped with other risk
factors. According to our step-wise multivariate logistic regres-
sion analysis, old age (aOR=1.72, 95% CI: 1.27–2.34),
hypertension (aOR=2.58, 95%CI: 1.31–5.08), history of stroke
(aOR=2.08 95% CI: 1.01–4.45), and hypercholesterolemia
(aOR=1.84, 95% CI: 1.01–3.35) were associated with RVO
after adjusting for all potential confounding factors.3.3. Association of RVO with hypertension control and
antihypertensive medication
Table 4 shows RVO associations according to degree of
hypertension, regardless of whether the patient was taking
hypertension medication. Multivariate logistic regression analy-
sis with adjustments for all potential confounding factors showed
that participants with controlled hypertension were not more
likely to have RVO than participants without hypertension
(aOR=2.03, 95% CI: 0.94–4.41). However, participants with
uncontrolled hypertension, including both stage 1 and stage 2
hypertension (aOR=3.46, 95%CI: 1.72–6.94), had signiﬁcantly
more RVO than participants without hypertension (stage 1
hypertension (aOR=2.76, 95% CI: 1.14–5.51) and stage 2
hypertension (aOR=6.84, 95% CI: 2.36–19.83)).
Table 5 shows the RVOassociations according to hypertension
control and antihypertensive medication. Multivariate logistic
regression analysis with adjustments for all potential confound-
ing factors showed no signiﬁcant difference in likelihood of RVO
between participants treated with antihypertensive medication
and normal participants (aOR=1.51, 95% CI: 0.72–3.17 in
patients with hypertension controlled by medication, aOR=
1.02, 95% CI: 0.35–3.00 in patients with hypertension
uncontrolled by medication), whereas hypertensive participantsal vein occlusion subtype.
Prevalence % (N)
Any RVO
Male Female Overall
0.1±0.1 (1) 0 (0) <0.1 (1)
<0.1% (1) <0.1 (2) <0.1 (3)
0.5±0.2 (8) 0.2±0.1 (5) 0.3±0.1 (13)
1.0±0.3 (16) 0.6±0.2 (19) 0.8±0.2 (35)
1.4±0.3 (26) 1.6±0.3 (37) 1.5±0.2 (63)
2.7±0.6 (27) 3.3±0.5 (49) 3.1±0.4 (76)
2.0±1.1 (4) 3.1±1.2 (10) 2.8±0.9 (14)
0.6±0.1 (83) 0.6±0.1 (122) 0.6±0.1 (205)
]).
Table 2
Comparison of characteristics between participants with and without retinal vein occlusion.
RVO (n=205) Non-RVO (n=25,560)
PWeighted estimated value Standard error Weighted estimated value Standard error
Age, y 62.7 1.2 44.3 0.9 <0.001
Sex, % female 52.5 4.3 50.5 0.3 0.637
Household income (%)
Lower quartile 41.7 4.3 20.0 0.5 <0.001
2nd quartile 26.2 4.0 26.0 0.6
3rd quartile 15.9 3.6 26.2 0.5
Upper quartile 16.2 3.3 27.7 0.7
Education
High school or less 53.1 4.3 30.4 0.6 <0.001
High school graduate 14.6 3.3 15.8 0.4
Some college 21.0 3.7 32.9 0.5
College graduate or more 11.3 3.1 20.9 0.6
HbA1c, % 6.11 0.2 5.8 0.0 0.086
Diabetes, % 14.6 3.5 7.7 0.2 0.011
Pulse pressure 51.0 1.42 40.9 0.1 <0.001
Metabolic syndrome components
Systolic blood pressure, mm Hg 133.4 1.9 117.3 0.2 <0.001
Diastolic blood pressure, mm Hg 82.5 1.3 76.5 0.1 <0.001
Body mass index, kg/m2 24.4 0.2 23.6 0.0 0.007
Fasting glucose, mg/dL 103.1 1.9 96.4 0.2 0.026
Hypertension, % 70.2 3.8 25.6 0.4 <0.001
Triglycerides, mg/dL 135.8 6.1 134.0 1.0 0.762
High-density lipoprotein, mg/dL 51.7 1.1 52.5 0.1 0.480
Low-density lipoprotein mg/dL 129.8 12.5 112.6 0.5 0.223
Total cholesterol, mg/dL 199.9 4.2 187.3 0.3 0.004
Metabolic syndrome, % 39.4 4.4 23.3 0.3 <0.001
History of angina or MI (%) 1.5 0.6 1.9 0.1 0.542
History of stroke (%) 7.5 1.8 1.2 0.1 <0.001
Chronic kidney disease (%) 5.8 1.7 1.5 0.1 0.010
Alcohol drinking, % 68.5 3.7 69.7 0.4 0.744
Current smoking, % 45.8 4.3 43.2 0.4 0.556
White blood cell count 6.0 0.1 6.1 0.0 0.663
Hematocrit 248.0 6.9 254.4 0.6 0.373
Ferritin 92.4 6.6 88.3 0.9 0.537
Vitamin D 18.5 0.5 17.8 0.1 0.146
Glaucoma, % 14.6 3.2 5.3 0.2 <0.001
Ocular perfusion pressure 49.0 3.8 37.4 1.1 0.005
History of cataract operation, % 2.1 0.9 0.8 0.1 0.018
Refractive errors (SE) 0.9 0.2 0.4 0.2 <0.001
MI=myocardial infarction, RVO= retinal vein occlusion, SE= spherical equivalents.
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likelihood of RVO than normal participants (aOR=3.08, 95%
CI: 1.53–6.21).4. Discussion
The population-based studies of RVO have mostly been
performed in white populations. The Blue Mountains Eye Study
(BMES) in Australia and the Beaver Dam Eye Study (BDES)
reported RVO prevalences of 1.6% and 0.8%, respectively.[1,5]
More recently, population-based epidemiologic studies on RVO
in nonwhite populations have been published. The RVO
prevalence in Asian populations older than 40 years was 0.7%
in the SingaporeMalay Eye Study (SiMES),[8] 1.2% in the Beijing
Eye Study,[7] 2.1% in the Hisayama Study,[10] 0.7% in the
Central India Eye and Medical Study (CIEMS),[11] and 0.72% in
the Singapore Epidemiology of Eye Disease Study (SEEDS).[13]
Our study showed an RVO prevalence of 0.6% (0.6% in BRVO
and <0.1% in CRVO) in adults ≥19 years old and 1.0% (0.9%5in BRVO and<0.1% in CRVO) in adults ≥40 years old, with no
signiﬁcant sex differences. Our prevalence estimates are moderate
compared to the previous results. These variations in RVO
prevalence might be due to racial, environmental, or methodo-
logical differences. Rogers et al[9] summarized RVO prevalence
using pooled data from worldwide studies and concluded that
age- and sex-standardized RVO prevalence were highly variable,
according to ethnicity (highest in Asians and Hispanics and
lowest in whites). Some studies have used epidemiologic data
obtained from speciﬁed areas, such as rural or urban communi-
ties, while our data were obtained from a nationwide health
survey, thereby reﬂecting a representative Korean population.
Our study also had the largest sample size among all
studies.[8,10,11]
In this study, we assessed all RVO risk factors that had been
signiﬁcant in previously published population-based studies. Of
demographic and socioeconomic factors, only old age was found
to be an independent risk factor of RVO in our study. Old age has
consistently been found to be one of the major RVO risk factors
[1,5,6,8]
Table 3
Logistic regression analyses of associations between potential risk factors and retinal vein occlusion.
Univariate analysis Age-adjusted multivariate analysis All-adjusted multivariate analysis
OR 95% CI P OR 95% CI P OR 95% CI P
Age (per 10 y) 2.07 1.86–2.30 <0.001 1.72 1.27–2.34 <0.001
Household income <0.001 0.331 0.151
Lower quartile Reference Reference Reference
2nd quartile 0.37 0.24–0.57 0.83 0.52–1.31 0.63 0.31–1.25
3rd quartile 0.22 0.12–0.37 0.65 0.36–1.17 0.33 0.12–0.92
Upper quartile 0.21 0.13–0.34 0.64 0.37–1.11 0.64 0.29–1.43
Education level <0.001 0.828 0.910
High school or less Reference Reference Reference
High school graduate 0.46 0.29–0.83 0.98 0.55–1.74 1.35 0.61–3.00
Some college 0.18 0.12–0.29 0.82 0.45–1.51 1.07 0.44–2.59
College graduate or more 0.13 0.08–0.23 0.72 0.34–1.53 1.10 0.34–3.66
HbA1c (per 1%) 1.24 1.06–1.46 0.009 1.00 0.72–1.38 0.975 0.98 0.54–1.79 0.994
Diabetes 2.03 1.17–3.54 0.012 0.88 0.50–1.57 0.675 0.54 0.20–1.50 0.216
Pulse pressure (per 1mm Hg) 1.05 1.04–1.06 <0.001 1.01 0.99–1.02 0.171 0.99 0.97–1.02 0.480
Body mass index (per 1 kg/m2) 1.06 1.02–1.10 0.002 1.05 1.01–1.10 0.019 1.01 0.94–1.09 0.876
Fasting glucose (per 1mg/dL) 1.01 1.00–1.01 <0.001 1.00 0.99–1.01 0.659 1.01 0.99–1.02 0.445
Hypertension 6.86 4.80–9.80 <0.001 2.99 1.94–4.60 <0.001 2.58 1.31–5.08 0.004
Hypercholesterolemia 3.14 2.07–4.77 <0.001 1.92 1.24–2.95 0.003 1.84 1.01–3.35 0.045
History of stroke 6.64 3.91–11.28 <0.001 2.29 1.31–4.01 0.004 2.08 1.01–4.45 0.049
Chronic kidney disease 4.01 2.17–7.43 <0.001 0.93 0.50–1.73 0.814 0.77 0.33–1.83 0.469
Glaucoma 3.08 1.85–5.12 <0.001 1.42 0.83–2.45 0.202 1.60 0.74–3.46 0.164
Ocular perfusion pressure 1.04 0.94–1.15 0.412 1.01 0.90–1.14 0.815
History of cataract operation 2.66 1.15–6.17 0.023 0.54 0.23–1.31 0.172 0.47 0.16–1.36 0.163
Refractive errors (SE) (per 1 diopter) 1.33 1.24–1.44 <0.001 1.02 0.92–1.13 0.771 0.98 0.88–1.09 0.679
CI= conﬁdence interval, OR=odds ratio, SE= spherical equivalents.
Shin et al. Medicine (2016) 95:44 Medicineacross many studies. Our study revealed that RVO
prevalence was very low in younger participants (lower than
0.1% 40 years) and increased with age. In particular, CRVO
was rare in people <70 years old and was observed more
frequently in older age groups compared to BRVO. This indicates
that RVO is an age-associated disease, and that functional and
structural changes in the retinal vessels as a function of aging
contribute to RVO pathogenesis. Current smoking was reported
to be an RVO-associated factor in the BDES, but we did not ﬁnd
the same pattern in our study.[8,10] No population-based studies,
including this one, have identiﬁed alcohol drinking as an
important RVO risk factor.[1,5–8,10,11,13]
Previous studies have reported that RVO shared several risk
factors with cardiovascular events (coronary heart diseases,
angina, and stroke), such as hypertension, diabetes, smoking, and
hypercholesterolemia.[1,5,6,8,22,23] According to our analyses,
hypertension presence, hypercholesterolemia, and stroke historyTable 4
Odds ratios and 95% conﬁdence intervals of retinal vein occlusion in
Model 1
OR 95% CI P for trend OR
Normal (reference) 1.00 <0.001 1.00
Controlled hypertension 7.06 4.21–11.84 2.22
Stage 1 hypertension 5.72 3.86–8.47 2.87
Stage 2 hypertension 11.50 6.56–20.20 5.53
Model 1=univariate, Model 2= age-adjusted, Model 3= adjusted for all factors signiﬁcant in univariate a
fasting glucose, hypercholesterolemia, history of stroke, chronic kidney diseases, glaucoma, history of c
CI= conﬁdence interval, OR=odds ratio.
6were signiﬁcantly associated with RVO. Hypertension has
consistently been identiﬁed as an RVO risk factor among many
previous studies, except the SiMES.[8] Diabetes was not a
signiﬁcant risk factor according to our study. Histories of angina,
myocardial infarction, and stroke and the presence of hypercho-
lesterolemia have been inconsistently reported as RVO risk
factors across several studies. Sample size, racial differences, and
environmental factors might inﬂuence any of the other known
risk factors. According to SEEDS, there were some differences in
signiﬁcance for RVO factors among 3 Asian ethnicities studied
(Chinese, Indian, and Malay).
Most previous population-based studies did not ﬁnd an
association between stroke history and RVO, except the
BMES.[1,5–8,10–13] In contrast to previous studies, our multivari-
ate logistic regression analysis showed that history of stroke was
a signiﬁcant risk factor of RVO. Recently, other studies have also
documented a higher stroke risk among RVO patients comparedpatients with hypertension according to hypertension control.
Model 2 Model 3
95% CI P for trend OR 95% CI P for trend
<0.001 1.00 <0.001
1.26–3.90 2.19 1.02–4.75
1.87–4.40 2.88 1.44–5.78
2.99–10.23 7.58 2.66–21.62
nalysis (age, household income, education level, HbA1c, diabetes, pulse pressure, body mass index,
ataract operation, and refractive errors).
[24–27]
Table 5
Odds ratios and 95% conﬁdence intervals of retinal vein occlusion in patients with hypertension according to hypertension medication.
Model 1 Model 2 Model 3
OR 95% CI P for trend OR 95% CI P for trend OR 95% CI P for trend
Normal (reference) 1.00 <0.001 1.00 <0.001 1.00 <0.001
Controlled hypertension with medication 6.99 4.20–11.62 2.19 1.23–3.89 2.05 0.93–4.52
Uncontrolled hypertension with medication 9.59 6.34–14.51 3.13 1.92–5.10 2.41 0.99–5.83
Hypertension without medication 5.80 3.67–9.16 3.69 2.26–6.02 4.12 2.01–8.46
Model 1=univariate, Model 2= age-adjusted, Model 3= adjusted for all factors signiﬁcant in univariate analysis (age, household income, education level, HbA1c, diabetes, pulse pressure, body mass index,
fasting glucose, hypercholesterolemia, history of stroke, chronic kidney diseases, glaucoma, history of cataract operation, and refractive errors).
CI= conﬁdence interval, OR=odds ratio.
Shin et al. Medicine (2016) 95:44 www.md-journal.comto non-RVO patients. On the other hand, while no studies
have evaluated the risk of developing RVO after stroke, our data
support the conclusion that RVO and stroke are risk factors of
each other, perhaps because the retina extends embryonically
from the brain, and retinal vessels share anatomical and
functional features with cerebral vessels (e.g., the blood–retinal
barrier is analogous to the blood–brain barrier).[28]
We evaluated the association between other potential
biochemical markers (hematocrit, serum ferritin, WBC count,
and vitamin D) and RVO. According to the Hisayama study,[10] a
higher plasma hematocrit level, which could increase blood
viscosity, was reported to be an independent risk factor of RVO.
Recently, abnormal serum ferritin level, WBC count, and vitamin
D were found to be associated with metabolic syndrome and
cardiovascular diseases.[29–31] Our study, however, did not show
any signiﬁcant associations between these factors and RVO.
We did not ﬁnd a signiﬁcant independent relationship between
metabolic syndrome and RVO. Our study revealed that, among
the components of metabolic syndrome, only blood pressure was
signiﬁcantly associated with RVO; this indicates that hyperten-
sion is the most important metabolic disorder in the development
of RVO. Therefore, we assessed the association between
hypertension and RVO in detail. Among hypertensive partic-
ipants, the OR for RVO increased with hypertension grade.
Participants with stage 2 hypertension had an RVO OR more
than 7 times greater than that of those without hypertension.
Interestingly, our study found that, if participants with
hypertension were taking antihypertensive medication, the
RVO OR was not signiﬁcantly higher than that of participants
without hypertension, whereas untreated hypertension was
signiﬁcantly associated with RVO (aOR=4.12, 95% CI:
2.01–8.46). We assumed that if, once patients began taking
antihypertensive medication, blood pressure was lower than the
initial pressure before medication, there was a period during
which blood pressure was dropping even if the patient’s blood
pressure was measured as being high at the survey time. Although
several types of data deﬁciencies limited our analyses, such as
longitudinal blood pressure, duration of hypertension, and
types of antihypertensive drugs taken, our results imply that
hypertension control and antihypertensive medication use are
crucial for preventing RVO. Previously, the BDES compared the
association between treated or untreated hypertension and RVO
and reported that treated hypertension was signiﬁcantly
associated with RVO (OR=6.85, 3.79, 10.24 in untreated,
treated controlled, and treated uncontrolled groups, respectively)
compared to normotension, which was different from our
ﬁndings.[1] However, these ﬁndings come from age-adjusted
logistic regression analysis, and the study used a different
deﬁnition for hypertension than we did (systolic blood pressure7≥160mm Hg or diastolic pressure ≥95mm Hg). Additionally,
our data might reﬂect the effectiveness of modern antihyperten-
sive medications because the BDES was performed more than 25
years ago.
Our multivariate regression analysis showed that no ophthal-
mologic factors were associated with RVO. Glaucoma is known
as a risk factor of RVO according to many previous small studies,
as well as the BMES.[5,32,33] However, other population-based
studies (BDES, SiMES, Beijing Eye Study, and CIEMS) have
suggested that glaucoma does not have a signiﬁcant relationship
with RVO prevalence, which was consistent with our
study.[1,7,8,11] In CIEMS and SEEDS, various ocular factors
were evaluated; however, only a narrow anterior chamber angle
was signiﬁcantly associated with RVO according to the
CIEMS[11,13] Both the BDES and the SiMES revealed that higher
ocular perfusion pressure was associated with RVO, while the
Beijing Eye Study, as well our study, did not ﬁnd a signiﬁcant
association between ocular perfusion pressure and RVO.[1,8,34]
Further studies are required to clarify which ocular factors are
signiﬁcantly associated with RVO.
Several issues and limitations should be considered when
interpreting our data. First, we could not determine any causal
relationships between risk factors and RVO because ours was a
cross-sectional study. A prospective longitudinal cohort study
would help to identify causal risk factors. Second, it is possible
that we underestimated RVO prevalence because only fundus
photographs centered on the macula were evaluated; this could
have resulted in missed cases of peripheral RVO. Third, we did
not divide RVO into BRVO and CRVO for identifying potential
risk factors because sample sizes for CRVO were too small to
perform robust statistical analyses. Despite these limitations, a
notable strength of our study was its large sample size compared
to the other population-based survey studies. Most previous
studies enrolled <50 subjects. Furthermore, most other studies
only included participants >40 years old, but our study included
all adult age groups (≥19 years old), and we presented prevalence
rates for the young age groups.[1,5,7,8,10,11,13] Third, the
KNHANES was a government-initiated study, thus requiring
that all aspects of the survey were performed using the
standardized protocol and well-trained examiners, which
produced qualiﬁed and validated health data from a representa-
tive Korean population.
In conclusion, we found a moderate RVO prevalence
compared to other studies. Conventional risk factors, such as
old age, hypertension, hypercholesterolemia, and history of
stroke, were also analyzed in the representative Korean
population. Hypertension, a particularly modiﬁable risk factor,
was the most strongly associated factor for RVO in our study.
Our results provide supporting evidence that well-controlled
[17] Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic
Shin et al. Medicine (2016) 95:44 Medicinehypertension and use of antihypertensive medication protect
against RVO occurrence, and that ophthalmologists should pay
attention to hypertension control as part of their ophthalmologic
treatment plan.
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